GlassScriptPhysician profile
Hady Lichaa
NPI 1336267533
$94,055.23
in general payments reported to CMS, 2019-2025
46 companies · $18K in 2025
The $18K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $1,093 · 2021: $5,733 · 2022: $23K · 2023: $18K · 2024: $13K · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Food and Beverage: $8,720 · Travel and Lodging: $8,566 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $7,600 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,900 · Honoraria: $2,800 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,862.50 |
| Food and Beverage | $8,720.38 |
| Travel and Lodging | $8,565.91 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $7,600.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,900.00 |
| Honoraria | $2,800.00 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $17,581.84 | 2019-2025 | Impella |
| Bard Peripheral Vascular, INC. | $14,978.16 | 2019-2021 | |
| Cordis US Corp. | $10,344.42 | 2021-2024 | Selution Slrptca, Mynx Control, Mynx Venous Vcd |
| Surmodics, INC. | $9,922.94 | 2023-2025 | Pounce Venous Thrombectomy System, Pounce Thrombectomy System, Pounce Thrombectomy |
| Shockwave Medical, INC | $9,545.24 | 2019-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $7,351.70 | 2022-2025 | (6554) Peripheral Vascular Undivided, Coronary Undivided, (Dd1) Duo Hybrid |
| Abbott Laboratories | $6,089.55 | 2019-2025 | Diamondback Peripheral, Optis, Hi-Torque Balance |
| Boston Scientific Corporation | $4,629.81 | 2020-2025 | Accolade Sr, Avvigo Guidance System, Watchman Access System |
| Penumbra, INC. | $4,474.05 | 2019-2025 | Indigo System |
| Medtronic, INC. | $3,848.61 | 2024-2025 | Abre, Turbohawk, Protege Rx |
| Medicure Pharma INC. | $900.00 | 2020-2021 | |
| Actelion Pharmaceuticals US, INC. | $580.41 | 2019-2024 | Uptravi, Opsumit |
| Janssen Pharmaceuticals, INC | $457.01 | 2019-2024 | Xarelto |
| Teleflex LLC | $392.69 | 2021-2023 | Trapliner |
| Angiodynamics, INC. | $357.24 | 2022-2024 | Auryon Laser System 100-120 Vac |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $332.96 | 2019-2022 | |
| Inari Medical, INC. | $325.70 | 2019-2021 | |
| Heartflow, INC. | $252.33 | 2023-2024 | Ffrct |
| Amgen INC. | $162.18 | 2019-2025 | Repatha |
| Endologix LLC | $150.13 | 2025 | Endocross Device, Torus Stent Graft System |
| Recor Medical INC | $147.60 | 2024 | Paradise Renal Denervation System |
| Merck Sharp & Dohme LLC | $141.24 | 2023-2025 | Winrevair, Verquvo |
| Novo Nordisk INC | $129.38 | 2023-2024 | Rybelsus, Ozempic, Wegovy |
| Cardiovascular Systems INC. | $123.33 | 2019-2023 | Diamondback Coronary |
| Astrazeneca Pharmaceuticals LP | $121.86 | 2021-2024 | Farxiga |
| Edwards Lifesciences Corporation | $104.03 | 2023 | |
| Daxor Corporation | $48.07 | 2023 | Bva-100 |
| Tactile Systems Technology INC | $44.70 | 2024 | Entre Plus, Flexitouch Plus |
| Novartis Pharmaceuticals Corporation | $44.06 | 2023-2024 | |
| Esperion Therapeutics, INC. | $43.38 | 2023-2024 | Nexletol |
| Cardinal Health 200 LLC | $42.07 | 2021 | |
| Smith+Nephew, INC. | $41.48 | 2022 | |
| Lantheus Medical Imaging, INC. | $39.12 | 2019-2023 | Definity |
| Pfizer INC. | $33.81 | 2023-2024 | |
| Lexicon Pharmaceuticals, INC. | $32.67 | 2023 | Inpefa |
| E.R. Squibb & Sons, L.L.C. | $28.70 | 2019-2023 | Eliquis |
| Arbor Pharmaceuticals, INC. | $28.42 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.42 | 2023 | Jardiance |
| Asahi Intecc USA, INC. | $27.33 | 2019 | |
| Becton, Dickinson and Company | $25.54 | 2021 | |
| Siemens Medical Solutions USA, INC. | $21.14 | 2021 | |
| Portola Pharmaceuticals, LLC | $19.00 | 2019 | |
| Haemonetics Corporation | $17.60 | 2023 | Teg6s Hemostasis System |
| Medtronic Vascular, INC. | $17.53 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.84 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $11.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hady Lichaa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.